Perrigo | PRGO - Frais De Vente Et D'Administration





Frais De Vente Et D'Administration Changement Date
AbbVie USD 3.58B 316M 2026-03
Abbott USD 3.27B 138M 2026-03
Bayer EUR 3.7B 356M 2026-03
Bristol-Myers Squibb USD 1.62B 564M 2026-03
Coherus Biosciences USD 15M 6.26M 2025-12
Corcept Therapeutics USD 128.04M 13.3M 2026-03
Dr.Reddys Laboratories INR 26.92B 482M 2025-12
Eli Lilly USD 2.93B 198M 2026-03
J&J USD 6.03B 719M 2026-03
Merck USD 2.67B 180M 2026-03
Nestle CHF 12.46B 267M 2025-12
Pacira USD 83.88M 7.99M 2026-03
Perrigo USD 267.3M 11.4M 2026-03
Pfizer USD 2.92B 1.16B 2026-03
Phibro Animal Health USD 78.32M 10.24M 2025-12
Prestige Brands USD 30.28M 606K 2026-03
Sanofi EUR 2.33B 419M 2026-03
Supernus Pharmaceuticals USD 118.23M 4.16M 2026-03
Teva Pharmaceutical Industries USD 1000M 120M 2026-03
Xeris Pharmaceuticals USD 53.14M 10.51M 2026-03
Zoetis USD 588M 31M 2026-03